{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:32:27Z","timestamp":1761863547517},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00467-016-3387-4","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T09:30:40Z","timestamp":1461922240000},"page":"1369-1373","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Significant improvement in Fabry disease podocytopathy after 3\u00a0years of treatment with agalsidase beta"],"prefix":"10.1007","volume":"31","author":[{"given":"Shuichi","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"3387_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276:1163\u20131167","journal-title":"N Engl J Med"},{"key":"3387_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jpeds.2010.02.012","volume":"156","author":"CL Marchesoni","year":"2010","unstructured":"Marchesoni CL, Roa N, Pardal AM, Neumann P, C\u00e1ceres G, Mart\u00ednez P, Kisinovsky I, Bianchi S, Tarabuso AL, Reisin RC (2010) Misdiagnosis in Fabry disease. J Pediatr 156:828\u2013831","journal-title":"J Pediatr"},{"key":"3387_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2377-11-61","volume":"11","author":"AP Burlina","year":"2011","unstructured":"Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C, M\u00f8ller AT, Hilz MJ (2011) Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol 11:61","journal-title":"BMC Neurol"},{"key":"3387_CR4","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","volume":"25","author":"AB Fogo","year":"2010","unstructured":"Fogo AB, Bostad L, Svarstad E, Cook WJ, Moll S, Barbey F, Geldenhuys L, West M, Ferluga D, Vujkovac B, Howie AJ, Burns A, Reeve R, Waldek S, No\u00ebl LH, Gr\u00fcnfeld JP, Valbuena C, Oliveira JP, M\u00fcller J, Breunig F, Zhang X, Warnock DG; International Study Group of Fabry Nephropathy (ISGFN) (2010) Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant 25:2168\u20132177","journal-title":"Nephrol Dial Transplant"},{"key":"3387_CR5","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/ndt\/gfq058","volume":"25","author":"H Machida","year":"2010","unstructured":"Machida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, Mori M, Inayama Y, Yan K, Kobayashi N, Yokota S (2010) Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol Dial Transplant 25:2530\u20132537","journal-title":"Nephrol Dial Transplant"},{"key":"3387_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neulet.2015.01.084","volume":"594","author":"L Choi","year":"2015","unstructured":"Choi L, Vernon J, Kopach O, Minett MS, Mills K, Clayton PT, Meert T, Wood JN (2015) The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain. Neurosci Lett 594:163\u2013168","journal-title":"Neurosci Lett"},{"key":"3387_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mus.20130","volume":"31","author":"D Lacomis","year":"2005","unstructured":"Lacomis D, Roeske-Anderson L, Mathie L (2005) Neuropathy and Fabry\u2019s disease. Muscle Nerve 31:102\u2013107","journal-title":"Muscle Nerve"},{"key":"3387_CR8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.20385","volume":"63","author":"I Pagnini","year":"2011","unstructured":"Pagnini I, Borsini W, Cecchi F, Sgalambro A, Olivotto I, Frullini A, Cimaz R (2011) Distal extremity pain as a presenting feature of Fabry\u2019s disease. Arthritis Care Res (Hoboken) 63:390\u2013395","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3387_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/8904_2011_14","volume":"1","author":"T Kanai","year":"2011","unstructured":"Kanai T, Yamagata T, Ito T, Odaka J, Saito T, Aoyagi J, Kobayashi M, Ohashi T, Ueda Y, Momoi MY (2011) Foot process effacement with normal urinalysis in classic Fabry disease. JIMD Rep 1:39\u201342","journal-title":"JIMD Rep"},{"key":"3387_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C T\u00f8ndel","year":"2013","unstructured":"T\u00f8ndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, Svarstad E (2013) Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol 24:137\u2013148","journal-title":"J Am Soc Nephrol"},{"key":"3387_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000369309","volume":"129","author":"C T\u00f8ndel","year":"2015","unstructured":"T\u00f8ndel C, Kanai T, Larsen KK, Ito S, Politei JM, Warnock DG, Svarstad E (2015) Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria. Nephron 129:16\u201321","journal-title":"Nephron"},{"key":"3387_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrneph.2013.169","volume":"9","author":"F Grahammer","year":"2013","unstructured":"Grahammer F, Schell C, Huber TB (2013) The podocyte slit diaphragm\u2014from a thin grey line to a complex signalling hub. Nat Rev Nephrol 9:587\u2013598","journal-title":"Nat Rev Nephrol"},{"key":"3387_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1681\/ASN.2006080816","volume":"18","author":"DP Germain","year":"2007","unstructured":"Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, Lee P, Loew T, Vedder AC, Abichandani R, Wilcox WR, Guffon N (2007) Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol 18:1547\u20131557","journal-title":"J Am Soc Nephrol"},{"key":"3387_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","volume":"146","author":"M Banikazemi","year":"2007","unstructured":"Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ, Fabry Disease Clinical Trial Study Group (2007) Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med 146:77\u201386","journal-title":"Ann Intern Med"},{"key":"3387_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","volume":"52","author":"DP Germain","year":"2015","unstructured":"Germain DP, Charrow J, Desnick RJ, Guffon N, Kempf J, Lachmann RH, Lemay R, Linthorst GE, Packman S, Scott CR, Waldek S, Warnock DG, Weinreb NJ, Wilcox WR (2015) Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J Med Genet 52:353\u2013358","journal-title":"J Med Genet"},{"key":"3387_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","volume":"62","author":"MJ Hilz","year":"2004","unstructured":"Hilz MJ, Brys M, Marthol H, Stemper B, D\u00fctsch M (2004) Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology 62:1066\u20131072","journal-title":"Neurology"},{"key":"3387_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/ndt\/gfr420","volume":"27","author":"DG Warnock","year":"2012","unstructured":"Warnock DG, Ortiz A, Mauer M, Linthorst GE, Oliveira JP, Serra AL, Mar\u00f3di L, Mignani R, Vujkovac B, Beitner-Johnson D, Lemay R, Cole JA, Svarstad E, Waldek S, Germain DP, Wanner C, Registry F (2012) Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant 27:1042\u20131049","journal-title":"Nephrol Dial Transplant"},{"key":"3387_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10067-010-1445-z","volume":"30","author":"R Cimaz","year":"2011","unstructured":"Cimaz R, Guillaume S, Hilz MJ, Horneff G, Manger B, Thorne JC, M\u00f8ller AT, Wulffraat NM, Roth J (2011) Awareness of Fabry disease among rheumatologists\u2014current status and perspectives. Clin Rheumatol 30:467\u2013475","journal-title":"Clin Rheumatol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-016-3387-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3387-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T02:56:59Z","timestamp":1718506619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-016-3387-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3387"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3387-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"assertion":[{"value":"8 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors has any conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments, or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent for publication of this case was obtained from the child and his parents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}